HealthStream(HSTM)
$27.18-0.45 (-1.63%)
HSTM
HealthStream financials statements
$27.18
At close:-0.45 (-1.63%)
Want to see HSTM full AI Analyst Report?
HealthStream (HSTM) Ratios
131 Followers
HealthStream Ratios
HSTM's free cash flow for Q3 2026 was $9.98M. For the 2026 fiscal year, HSTM's free cash flow was decreased by $-7.41M and operating cash flow was $17.39M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.96 | 1.32 | 1.10 | 0.98 | 1.06 |
| Quick Ratio | 0.96 | 1.32 | 1.10 | 0.98 | 1.06 |
| Cash Ratio | 0.29 | 0.51 | 0.34 | 0.39 | 0.47 |
| Solvency Ratio | 0.37 | 0.40 | 0.35 | 0.31 | 0.29 |
| Operating Cash Flow Ratio | 0.51 | 0.50 | 0.54 | 0.44 | 0.42 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -46.70M | $ 1.71M | $ -28.98M | $ -49.30M | $ -40.89M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 |
| Debt-to-Equity Ratio | 0.04 | 0.06 | 0.06 | 0.07 | 0.09 |
| Debt-to-Capital Ratio | 0.04 | 0.05 | 0.06 | 0.07 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.47 | 1.42 | 1.47 | 1.49 | 1.44 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.49 | 0.66 | 0.66 | 0.76 | 0.92 |
| Net Debt to EBITDA | -0.32 | -0.60 | -0.35 | -0.45 | -0.40 |
| Profitability Margins | |||||
| Gross Profit Margin | 64.74% | 66.42% | 65.95% | 65.84% | 64.54% |
| EBIT Margin | 7.64% | 8.50% | 5.74% | 4.67% | 3.14% |
| EBITDA Margin | 21.93% | 22.65% | 20.46% | 18.89% | 17.48% |
| Operating Profit Margin | 6.66% | 7.30% | 5.74% | 4.67% | 3.14% |
| Pretax Profit Margin | 7.64% | 8.50% | 6.63% | 5.84% | 3.03% |
| Net Profit Margin | 6.03% | 6.86% | 5.45% | 4.53% | 2.28% |
| Continuous Operations Profit Margin | 6.03% | 6.86% | 5.45% | 4.53% | 2.28% |
| Net Income Per EBT | 79.00% | 80.66% | 82.18% | 77.58% | 75.26% |
| EBT Per EBIT | 114.74% | 116.52% | 115.56% | 125.19% | 96.41% |
| Return on Assets (ROA) | 3.52% | 3.92% | 3.04% | 2.43% | 1.20% |
| Return on Equity (ROE) | 5.18% | 5.57% | 4.46% | 3.62% | 1.72% |
| Return on Capital Employed (ROCE) | 5.11% | 5.39% | 4.20% | 3.27% | 2.08% |
| Return on Invested Capital (ROIC) | 4.03% | 4.32% | 3.45% | 2.54% | 1.56% |
| Return on Tangible Assets | 9.54% | 9.07% | 7.61% | 6.48% | 3.20% |
| Earnings Yield | 2.65% | 2.07% | 1.84% | 1.59% | 0.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.80 | 8.26 | 7.26 | 6.25 | 7.35 |
| Payables Turnover | 13.80 | 14.78 | 12.73 | 12.51 | 17.76 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 11.72 | 10.34 | 8.43 | 6.98 | 5.95 |
| Asset Turnover | 0.58 | 0.57 | 0.56 | 0.54 | 0.53 |
| Working Capital Turnover Ratio | 18.46 | 11.84 | 61.92 | 145.85 | 288.76 |
| Cash Conversion Cycle | 20.36 | 19.50 | 21.61 | 29.24 | 29.10 |
| Days of Sales Outstanding | 46.81 | 44.21 | 50.29 | 58.42 | 49.65 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 26.45 | 24.70 | 28.67 | 29.18 | 20.55 |
| Operating Cycle | 46.81 | 44.21 | 50.29 | 58.42 | 49.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.11 | 1.90 | 2.09 | 1.67 | 1.34 |
| Free Cash Flow Per Share | 1.99 | 0.97 | 2.02 | 1.61 | 1.24 |
| Dividend Paid and CapEx Coverage Ratio | 8.54 | 1.83 | 12.17 | 28.95 | 12.34 |
| Capital Expenditure Coverage Ratio | 17.18 | 2.05 | 29.08 | 28.95 | 12.40 |
| Operating Cash Flow Coverage Ratio | 4.31 | 2.86 | 3.16 | 2.19 | 1.46 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.20 | 0.23 | 0.19 | 0.17 |
| Free Cash Flow Yield | 8.61% | 3.05% | 7.48% | 6.49% | 4.69% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 37.82 | 48.18 | 54.32 | 62.96 | 142.21 |
| Price-to-Sales (P/S) Ratio | 2.28 | 3.31 | 2.96 | 2.85 | 3.24 |
| Price-to-Book (P/B) Ratio | 1.96 | 2.69 | 2.43 | 2.28 | 2.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.61 | 32.74 | 13.38 | 15.40 | 21.33 |
| Price-to-Operating Cash Flow Ratio | 10.94 | 16.76 | 12.92 | 14.87 | 19.61 |
| Price-to-Earnings Growth (PEG) Ratio | -4.99 | 1.51 | 1.93 | 0.60 | -2.50 |
| Enterprise Value Multiple | 10.06 | 14.04 | 14.12 | 14.66 | 18.13 |
| Enterprise Value | 671.04M | 926.97M | 806.25M | 738.59M | 813.44M |
| EV to EBITDA | 10.06 | 14.04 | 14.12 | 14.66 | 18.13 |
| EV to Sales | 2.21 | 3.18 | 2.89 | 2.77 | 3.17 |
| EV to Free Cash Flow | 11.25 | 31.40 | 13.05 | 14.95 | 20.87 |
| EV to Operating Cash Flow | 10.60 | 16.08 | 12.60 | 14.43 | 19.19 |
| Tangible Book Value Per Share | 0.87 | 2.28 | 1.33 | 0.75 | 1.11 |
| Shareholders’ Equity Per Share | 11.79 | 11.83 | 11.15 | 10.90 | 10.75 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.19 | 0.18 | 0.22 | 0.25 |
| Revenue Per Share | 10.13 | 9.60 | 9.13 | 8.71 | 8.14 |
| Net Income Per Share | 0.61 | 0.66 | 0.50 | 0.39 | 0.19 |
| Tax Burden | 0.79 | 0.81 | 0.82 | 0.78 | 0.75 |
| Interest Burden | 1.00 | 1.00 | 1.16 | 1.25 | 0.96 |
| Research & Development to Revenue | 0.17 | 0.17 | 0.16 | 0.17 | 0.16 |
| SG&A to Revenue | 0.27 | 0.28 | 0.13 | 0.14 | 0.15 |
| Stock-Based Compensation to Revenue | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 |
| Income Quality | 3.45 | 2.88 | 4.20 | 4.23 | 7.25 |
Currency in USD

